본문으로 건너뛰기
ProhibitedBinding ruleBROfficial English translation공식 출처 가져오기 확인됨

Flumioxazina

ANVISA lists this substance among materials that may not be used in personal-hygiene products, cosmetics or perfumes in Brazil.

규제 판단 및 전체 조건

상태
Prohibited
법적 역할
Binding rule
규제 요약
ANVISA lists this substance among materials that may not be used in personal-hygiene products, cosmetics or perfumes in Brazil.
조건 및 제한 사항

Flumioxazina

물질 정체

공식 출처상의 명칭
Flumioxazina
CAS
103361-09-7
EC
Not supplied in this source row
정체 매핑
standalone:official_anvisa_record

이 정체의 시장 간 요약

현재 이 사이트에 있는 정확히 연결된 기록입니다. 시장이 없는 것은 가져온 정확한 일치 항목이 없다는 뜻이며, 해당 물질의 사용이 허용된다는 뜻이 아닙니다.

시장 데이터세트 9개

Brazil

현재 기록
Prohibited

연결된 기록 1건 · 특정 조건이 있는 기록 1건

보조 기록 열기
CAS 103361-09-7의 PubChem 2D 화학 구조
CAS 103361-09-7PubChem CID 92425

CAS 103361-09-7의 검증된 화학 정보

Flumioxazin

Flumioxazin is a benzoxazine that is N-(prop-2-yn-1-yl)-2H-1,4-benzoxazin-3(4H)-one which is substituted at position 6 by a 1,3-dioxo-1,3,4,5,6,7-hexahydro-2H-isoindol-2-yl group and at position 7 by a fluorine. A protoporphyrinogen oxidase inhibitor, it is used for the control of weeds in soya, peanuts, and a variety of vegetable and fruit crops. It has a role as a herbicide, an agrochemical, a teratogenic agent and an EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor. It is a dicarboximide, an organofluorine compound, a benzoxazine and a terminal acetylenic compound. — ChEBI

IUPAC 명칭
2-(7-fluoro-3-oxo-4-prop-2-ynyl-1,4-benzoxazin-6-yl)-4,5,6,7-tetrahydroisoindole-1,3-dione
분자식
C19H15FN2O4
분자량
354.3 g/mol
정확한 질량
354.10158513 Da
단일 동위원소 질량
354.10158513 Da
XLogP3
1.8
위상 극성 표면적
66.9 Ų
분자 복잡도
724.0
형식 전하
0
수소 결합 공여체
0
수소 결합 수용체
5
회전 가능 결합
2
중원자
26
공유결합 단위
1

PubChem에 보고된 명칭 및 동의어

SumisoyaS-53482VALORS 53482V 53482EINECS Annex I Index 613-166-00-XL0PX7OGI22CHEBI:8939
보고된 명칭 16개 더 보기
7-Fluoro-6-(3,4,5,6-tetrahydrophthalimido)-4-(2-propynyl)-1,4-benzoxazin-3(2H)-one7-fluoro-6-((3,4,5,6-tetrahydro)phthalimido)-4-(2-propynyl)-1,4-benzoxazin-3(2 H)-oneV-53482n-(7-fluoro-3,4-dihydro-3-oxo-4-prop-2-ynyl-2h-1,4-benzoxazin-6-yl)cyclohex-1-ene-1,2-dicarboxamide2-(7-fluoro-3-oxo-4-(prop-2-yn-1-yl)-3,4-dihydro-2H-1,4-benzoxazin-6-yl)-2,3,4,5,6,7-hexahydro-1H-isoindole-1,3-dione2-[7-fluoro-3-oxo-4-(prop-2-yn-1-yl)-3,4-dihydro-2H-1,4-benzoxazin-6-yl]-2,3,4,5,6,7-hexahydro-1H-isoindole-1,3-dioneRefChem:1408481H-Isoindole-1,3(2H)-dione, 2-(7-fluoro-3,4-dihydro-3-oxo-4-(2-propyn-1-yl)-2H-1,4-benzoxazin-6-yl)-4,5,6,7-tetrahydro-Flumioxazin [ISO]Sumisoya; V 534822-[7-Fluoro-3,4-dihydro-3-oxo-4-(2-propyn-1-yl)-2H-1,4-benzoxazin-6-yl]-4,5,6,7-tetrahydro-1H-isoindole-1,3(2H)-dioneFlumioxazineFlumizinFlumioxazin Solution in Acetonitrile1H-Isoindole-1,3(2H)-dione,2-[7-fluoro-3,4-dihydro-3-oxo-4-(2-propynyl)-2H-1,4-benzoxazin-6-yl]-4,5,6,7-tetrahydro-2-[7-fluoro-3-oxo-4-(prop-2-yn-1-yl)-3,4-dihydro-2H-1,4-benzoxazin-6-yl]-4,5,6,7-tetrahydro-1H-isoindole-1,3(2H)-dione
외부 데이터베이스 식별자
고급 구조 통계
정의된 원자 입체중심
0
정의되지 않은 원자 입체중심
0
정의된 결합 입체중심
0
정의되지 않은 결합 입체중심
0
3D 파마코포어 특성
9
3D 고리
4
3D 소수성 부위
1
3D 수용체 특성
4
3D 공여체 특성
0
3D 음이온 중심
0
3D 양이온 중심
0
3D 형태이성질체
6
유효 3D 회전자
3.6
기계 판독 가능한 구조 식별자
SMILES
C#CCN1C(=O)COC2=CC(=C(C=C21)N3C(=O)C4=C(C3=O)CCCC4)F
InChI
InChI=1S/C19H15FN2O4/c1-2-7-21-15-9-14(13(20)8-16(15)26-10-17(21)23)22-18(24)11-5-3-4-6-12(11)19(22)25/h1,8-9H,3-7,10H2
InChIKey
FOUWCSDKDDHKQP-UHFFFAOYSA-N

추가 과학 데이터베이스의 근거

EMBL-EBI ChEBI
식별자 정확히 일치CHEBI:8939

flumioxazin

A benzoxazine that is N-(prop-2-yn-1-yl)-2H-1,4-benzoxazin-3(4H)-one which is substituted at position 6 by a 1,3-dioxo-1,3,4,5,6,7-hexahydro-2H-isoindol-2-yl group and at position 7 by a fluorine. A protoporphyrinogen oxidase inhibitor, it is used for the control of weeds in soya, peanuts, and a variety of vegetable and fruit crops.

처방
C19H15FN2O4
평균 질량
354.337 g/mol
단일 동위원소 질량
354.10159 Da
형식 전하
0
  • benzoxazine — is a (CHEBI:46969)
  • terminal acetylenic compound — is a (CHEBI:73477)
  • dicarboximide — is a (CHEBI:35356)
  • organofluorine compound — is a (CHEBI:37143)
  • teratogenic agent — has role (CHEBI:50905)
  • herbicide — has role (CHEBI:24527)
  • agrochemical — has role (CHEBI:33286)
  • EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor — has role (CHEBI:73192)
  • teratogenic agent — has role (CHEBI:50905)
  • herbicide — has role (CHEBI:24527)
  • agrochemical — has role (CHEBI:33286)
  • EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor — has role (CHEBI:73192)
  • benzoxazine — is a (CHEBI:46969)
  • terminal acetylenic compound — is a (CHEBI:73477)
  • dicarboximide — is a (CHEBI:35356)
  • organofluorine compound — is a (CHEBI:37143)
추가 선별 명칭
2-[7-fluoro-3-oxo-4-(prop-2-yn-1-yl)-3,4-dihydro-2H-1,4-benzoxazin-6-yl]-4,5,6,7-tetrahydro-1H-isoindole-1,3(2H)-dione2-[7-fluoro-3,4-dihydro-3-oxo-4-(2-propyn-1-yl)-2H-1,4-benzoxazin-6-yl]-4,5,6,7-tetrahydro-1H-isoindole-1,3(2H)-dione7-fluoro-6-(3,4,5,6-tetrahydrophthalimido)-4-(2-propynyl)-1,4-benzoxazin-3(2H)-oneN-(7-fluoro-3,4-dihydro-3-oxo-4-prop-2-ynyl-2H-1,4-benzoxazin-6-yl)cyclohex-1-ene-1,2-dicarboxamideflumioxazineS 53482S-53482V 53482
이 출처의 상호 참조
  • CAS: 103361-09-7 — Alan Wood's Pesticides
  • CAS: 103361-09-7 — KEGG COMPOUND
  • CAS: 103361-09-7 — ChemIDplus
  • MANUAL_X_REF: 335 — PPDB
  • MANUAL_X_REF: C11035 — KEGG COMPOUND
  • MANUAL_X_REF: flumioxazin — Alan Wood's Pesticides
  • MANUAL_X_REF: HMDB0034854 — HMDB
  • REGISTRY_NUMBER: 8290535 — Reaxys

매핑 기준: Exact CAS cross-reference in the ChEBI compound record. 출처 업데이트: 2017-08-11. 가져온 시각: 2026-08-31. 출처 기록 열기

NIH PubChem PUG-View
식별자 정확히 일치92425

Attributed physical-property, hazard, environmental and use annotations.

  • Environmental Bioconcentration: An estimated BCF of 18 was calculated for flumioxazin(SRC), using an experimental log Kow of 2.55(1) and a regression-derived equation(2). According to a classification scheme(3), this BCF suggests the potential for bioconcentration in aquatic organisms is low(SRC). 출처: Hazardous Substances Data Bank (HSDB)
  • Environmental Fate: TERRESTRIAL FATE: Based on column leaching studies and the short aerobic soil half-life, the potential for flumioxazin to leach in field agricultural soil is low(1). In soils that have been treated with flumioxazin, it is generally not found below 3 inches in depth(2). Volatilization losses from soil surfaces are negligible(1). Flumioxazin degrades rapidly in soil water via hydrolysis with half-lives of 3.4 to 5.1 days at pH 5.0, 21.4-24.6 hours at pH 7.0, and 14.6-22.0 minutes at pH 9.0(1); therefore, aqueous hydrolysis in moist soils will be an important fate process(SRC). Microbial degradation in soil is also an important fate process(1); the half-life for aerobic soil metabolism is 11.9 to 17.5 days, with an average of 14.7 days(1,2). The photolysis half-life on soil is 3.2 to 8.4 days (average 5.8 days)(2). The rapid soil dissipation rate indicates flumioxazin is not persistent in soil(1). 출처: Hazardous Substances Data Bank (HSDB)
  • Environmental Fate: AQUATIC FATE: Based on a classification scheme(1), an estimated Koc value of 13000(SRC), determined from a structure estimation method(2), indicates that flumioxazin is expected to adsorb to suspended solids and sediment(SRC). The hydrolytic degradation half-life of flumioxazin in soil water is 3.4 to 5.1 days at pH 5.0, 21.4-24.6 hours at pH 7.0, and 14.6-22.0 minutes at pH 9.0(3); therefore, hydrolysis will be the major degradation process in water(SRC). An anaerobic aquatic metabolism half-life of 0.2 days has been reported(4). The photolysis half-life in water at pH 5 is 1 day(4). Volatilization from water surfaces is expected to be slow(5) based upon an estimated Henry's Law constant of 6.28X10-7 atm-cu m/mole(SRC), derived from its vapor pressure, 2.41X10-6 mm Hg(6), and water solubility, 1.79 mg/l(4). Using this estimated Henry's Law constant and an estimation method(5), volatilization half-lives for a model river and model lake are 1,765 hours and 809 days, respectively(SRC). According to a classification scheme(7), an estimated BCF of 18(SRC), from a log Kow of 2.55(4) suggests the potential for bioconcentration in aquatic organisms is low(SRC). 출처: Hazardous Substances Data Bank (HSDB)
  • Environmental Fate: ATMOSPHERIC FATE: According to a model of gas/particle partitioning of semivolatile organic compounds in the atmosphere(1), flumioxazin, which has a vapor pressure of 2.41X10-6 mm Hg at 25 °C (2), will exist in both the vapor and particulate phases in the ambient atmosphere. Vapor-phase flumioxazin is degraded in the atmosphere by reaction with photochemically-produced hydroxyl radicals(SRC); the half-life for this reaction in air is estimated to be 6.8 hours(SRC), calculated from its rate constant of 5.68X10-11 cu cm/molecule-sec at 25 °C(SRC) (that was derived using a structure estimation method(3). Particulate-phase flumioxazin may be removed from the air by wet and dry deposition(SRC). 출처: Hazardous Substances Data Bank (HSDB)

매핑 기준: Existing checksum-valid CAS to unique PubChem CID match. 가져온 시각: 2026-08-31. 출처 기록 열기

과학적 분류와 유해성 주석은 맥락을 제공할 뿐이며, 위에 표시된 시장별 규제 판단을 대체하지 않습니다.

추가 출처 적용 범위 및 일치 상태
출처결과확인됨
EMBL-EBI ChEBI정확히 일치2026-08-31
NIH PubChem PUG-View정확히 일치2026-08-31

기록된 불일치는 출처를 확인했다는 유용한 근거이며, 해당 물질이 다른 곳에 존재하지 않는다는 주장이 아닙니다.

체크섬이 유효한 CAS 일치를 통해 2026-09-02에 NIH PubChem에서 가져왔습니다. 화학적 특성은 이 페이지의 규제 판단을 대체하지 않습니다.

공식 출처 및 출처 정보

등록된 출처
Brazil ANVISA consolidated prohibited substances — RDC 529/2021 through RDC 1.030/2026
출처 참조
RDC 529/2021 consolidated annex, entry 736 (through RDC 1.030/2026)
출처 기록 ID
annex:736
출처 버전
RDC 529/2021 consolidated through RDC 1.030/2026
출처 언어
Portuguese with official English identity where published
번역 상태
Official English translation · 영문 번역
시행일
2026-06-15
출처 업데이트
2026-06-15
스냅샷 확인
2026-08-31 15:26 UTC
검증 방법
pdfplumber government baseline + 4 RDC 1.030 exclusions + 15 additions; 1,387 substantive rows
SHA-256
a212e85540a186a842664fbdd4f351af0b1b4baeeb0c4765b9b52c6ce91c1e84

등록된 데이터세트 주석

데이터세트 적용 범위
All 1,387 substantive current prohibited rows after applying RDC 1.030/2026 additions, amendments and exclusions to RDC 529/2021
권위 관련 주석
Binding consolidated prohibited list for personal-hygiene products, cosmetics and perfumes

이 기록이 시장 데이터세트에서 차지하는 위치

1387
현재 Brazil 기록
1387
Prohibited(으)로 표시된 기록
1387
이 출처 버전의 기록
1335
CAS 정체가 있는 시장 기록

상태 분포

현재 기록 1387건 중 1387건에 조건 텍스트가 있습니다. 조건 필드가 비어 있는 경우 위의 기록 유형에 따라 해석되며, 제한 없는 사용에 대한 주장으로 전환되지 않습니다.

Brazil 시장 맥락

Complete prohibited dataset plus current restricted-list workflow

적용 범위 버전: ANVISA RDC 1.029/2026 and RDC 1.030/2026, published 15 June 2026

All 1,387 substantive current prohibited rows in RDC 529/2021 consolidated through RDC 1.030/2026, plus the current RDC 1.029 restricted-list and identity workflow.

확인 체크리스트

  1. Resolve Portuguese, INCI and CAS identity with the ANVISA crosswalk.
  2. Check the consolidated prohibited list including RDC 1.030/2026 changes.
  3. Apply RDC 1.029/2026 restrictions and the still-effective complementary rules.
  4. Verify Mercosur incorporation, regularisation, labelling and transition periods.

공식 시장 출처

확인 절차 및 기록 완전성

이 결과를 규제 준수 판단에 사용하기 전에

  1. “Flumioxazina”와(과) 모든 CAS/EC 식별자가 공급업체 규격서의 물질을 가리키는지 확인하세요.
  2. Resolve Portuguese, INCI and CAS identity with the ANVISA crosswalk.
  3. Check the consolidated prohibited list including RDC 1.030/2026 changes.
  4. Apply RDC 1.029/2026 restrictions and the still-effective complementary rules.
  5. Verify Mercosur incorporation, regularisation, labelling and transition periods.
  6. 출처 버전을 기록하고, 제조, 신고 또는 시장 출시 전에 규제 기관을 다시 확인하세요.

이 기록에서 제공되는 필드

  • 공식 물질 명칭제공됨
  • CAS제공됨
  • EC제공되지 않음
  • 별도의 조건 텍스트제공됨
  • 시행일제공됨
  • 스냅샷 해시 및 방법제공됨

이 페이지가 답하는 질문

This official record identifies the substance as prohibited for cosmetic use in the stated market scope. Do not rely on a formulation containing this identity until the cited source, effective date and exact substance match have been verified.

A prohibition entry may contain no separate condition text because the regulatory outcome is the prohibition itself. RDC 1.030/2026 amends rather than replaces the prohibited baseline, and the second restricted-list revision was still under consultation in July 2026.

이 기록은 RDC 529/2021 consolidated annex, entry 736 (through RDC 1.030/2026), 출처 버전 RDC 529/2021 consolidated through RDC 1.030/2026을(를) 인용합니다. 공식 출처를 여세요.

아니요. CAS는 정체를 확인하는 데 도움이 되지만, 관할권마다 같은 물질을 다르게 분류할 수 있으며 제품 범위, 한도, 경고 문구 및 경과 기간 날짜를 다르게 적용할 수 있습니다.

안정적인 인용

Flumioxazina. RDC 529/2021 consolidated annex, entry 736 (through RDC 1.030/2026). Brazil. Source version RDC 529/2021 consolidated through RDC 1.030/2026. CosIng Checker regulatory record: https://cosingchecker.com/ko/regulations/br/records/13936/

법적 권위로서 규제 기관을 인용하세요. 이 페이지는 구조화된 근거 색인이자 확인 보조 도구이며, 공식 본문이나 전문적인 법률 평가를 대체하지 않습니다.

Brazil의 해석 및 한계

This official record identifies the substance as prohibited for cosmetic use in the stated market scope.

Do not rely on a formulation containing this identity until the cited source, effective date and exact substance match have been verified.

법적 역할 해석 방법

The cited row forms part of a binding rule or legally incorporated list for this market.

이 페이지의 근거

  • 기록된 결과: Prohibited
  • 법적 역할: Binding rule
  • 출처 버전: RDC 529/2021 consolidated through RDC 1.030/2026
  • 시행일: 2026-06-15

증명하지 않는 것

RDC 1.030/2026 amends rather than replaces the prohibited baseline, and the second restricted-list revision was still under consultation in July 2026.

추가 공신력 있는 물질 조사

이 출처들 중 어느 것도 위의 시장 판단을 번복하지 않습니다.

Cosmetic Ingredient Review safety assessments

Expert Panel conclusions, assessed ingredient groups, use conditions, dates and report documents

Independent expert review considered by FDA; not a government approval or binding market rule

출처에서 이 정체 조사

FDA Global Substance Registration System

UNII identifiers, preferred names, substance types, codes and public substance relationships

Identity registry only; UNII availability does not imply FDA review or approval

출처에서 이 정체 조사

ILO/WHO International Chemical Safety Cards

Hazards, symptoms, first aid, storage, incompatibilities and physical properties for covered chemicals

International occupational chemical-safety reference; not cosmetic-use approval

출처에서 이 정체 조사

Japan NITE-CHRIP

Chemical identity, Japanese and foreign legal lists, GHS hazards and exposure-related information

Chemical-management evidence; cosmetic status remains governed by the applicable MHLW standard and market rules

출처에서 이 정체 조사

NIOSH Pocket Guide to Chemical Hazards

REL, PEL, IDLH, properties, exposure routes, symptoms, target organs, first aid and measurement methods for covered workplace chemicals

US occupational-health guidance and limits; not a cosmetic ingredient decision

출처에서 이 정체 조사

OECD eChemPortal

Gateway to authority-owned physical-property, fate, ecotoxicity, toxicity, exposure and GHS records

Discovery gateway; each linked authority remains responsible for its data

출처에서 이 정체 조사

US EPA CompTox CTX APIs

가져오기에 API 키 필요

DTXSID identity, experimental and predicted properties, toxicity, bioactivity, exposure and environmental data

Scientific and computational evidence; predictions must remain labelled and do not determine cosmetic legality

출처에서 이 정체 조사